Markey Cancer Center
Lexington, Kentucky, 40536, United States
NCT Number: NCT01810627
This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.
Looking for future studies?
Notify Me50 year–80 year
Male
Observational
Lexington, Kentucky, 40536, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Male 50-80 years of age Eligible for interstitial brachytherapy implants
Exclusion criteria
-
Patients will receive an additional MVCT scan at their one month follow up visit.
Time frame: One month post implant
Change in prostate volume measured with trans-rectal ultrasound at baseline versus prostate volume measured with KVCT and MVCT.
William St Clair
Other
Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02009449
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT05708950
Adnexal Diseases, Breast Cancer
Santa Monica, California, United States
View Trial DetailsNCT04582656
Genital Diseases, Genital Diseases, Male
Brussels, Belgium
View Trial DetailsNCT01804712
Genital Diseases, Genital Diseases, Male
La Jolla, California, United States
View Trial Details